Skip to main content

Table 2 Inflammation levels after CPAP treatment in OSAS patients

From: The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome

Reference

Number of patients

Treatment duration

Daily duration

Detecting parameter

Before treatment

After treatment

Schiza et al. 2010 [60]

528

12 months

≥ 4 h/night

CRP

CRP↑

CRP↓

Steiropoulos et al. 2009 [61]

52

6 months

≥ 4 h/night

TNF-α, IL-6, UA and CD4+ cell count

TNF-α↑ UA↑

CD4+ cell count↑

TNF-α↓

UA↓

CD4+ cell count↓

Yokoe et al. 2003 [62]

30

1 month

NA

CRP, IL-6

CRP↑

IL-6↑

CRP↓

IL-6↓

Jin et al. 2017 [63]

100

3 months

NA

IL-8, TNF-α, CRP, ICAM-1, VCAM-1, and selectin

IL-8↑

TNF-α↑

CRP↑

ICAM-1↑

VCAM-1↑

selectin↑

IL-8↓

TNF-α↓

CRP↓↓

ICAM-1↓

VCAM-1↓

selectin↓

Wu et al. 2010 [64]

30

2 months

NA

HMGB1 and NOx

HMGB1↑

NOx ↓

HMGB1↓

NOx↑

Kuramoto et al. 2009 [65]

116

3 months

NA

SAA, CRP

CRP↑

SSA↑

SAA↓

Ohga et al. 2003 [66]

20

8–18 months

NA

ICAM-1, IL-8, MCP-1

ICAN-1↑

IL-8↑

MCP-1↑

ICAM-1↓

IL-8↓

Lu et al. 2017 [67]

58

2 months

NA

NF-κB, HIF-1α and SPD

NF-κB↑

HIF-1α↑

SPD↓

SPD↑

NF-κB↓

HIF-1α↓

Tichanon et al. 2016 [68]

13

3 months

≥ 5 h/night

FeNO, MDA

FeNO↑

MDA↑

FeNO↓

MDA↓

  1. CRP C-reactive protein, TNF-α tumor necrosis factor-α, IL interleukin, ICAM-1 intercellular adhesion molecules-1, VCAM-1 vascular cell adhesion molecule-1, UA uric acid, NF-κB nuclear factor kappa B, HMGB1 high mobility group box 1, NOx nitric oxide derivative, SSA serum amyloid A, MCP-1 monocyte chemoattractant protein-1, HIF-1α hypoxia-inducible factor-1α, SPD surfactant protein D, FeNO fractional exhaled nitric oxide, MDA malondialdehyde, NA not administrated